Skip to main content
Top
Published in: BMC Primary Care 1/2022

Open Access 01-12-2022 | Gout | Research

Professionals’ perspectives on existing practice and conditions for nurse-led gout care based on treatment recommendations: a qualitative study in primary healthcare

Authors: Helene Sedelius, Malin Tistad, Ulrika Bergsten, Mats Dehlin, David Iggman, Lars Wallin, Anna Svärd

Published in: BMC Primary Care | Issue 1/2022

Login to get access

Abstract

Background

Gout affects nearly 2 % of the population and is associated with repeated painful flares of arthritis. Preventive urate-lowering therapy is widely available, but only one third of patients receive adequate treatment. Lack of knowledge among healthcare professionals and patients within primary healthcare are implicated as partial explanations for this undertreatment. Nurse-led care has proved to be an effective model when treating patients with gout, but there is a need for more knowledge about factors that can be expected to influence the future implementation of such care. The aim of this study was to describe factors influencing existing gout care in primary healthcare and the conditions for a future implementation of nurse-led gout care based on national treatment recommendations.

Methods

In this qualitative study, focus group discussions with 56 nurses and physicians and individual interviews with eight managers were conducted at nine primary healthcare units in central Sweden. A deductive qualitative content analysis based on the main constructs of the framework Integrated Promoting Action on Research Implementation in Health Services was followed by an inductive analysis within the frames of the main constructs: innovation, recipients and context.

Results

Gout-related contacts with primary healthcare was described as being patient initiated, diagnostics was in some respects complex and nurse-led care was experienced as a favourable primary healthcare model in general (innovation). Gout was seen as a low-priority condition with acute flares and there was inadequate knowledge of gout, including preventive treatment (recipients). Primary healthcare was perceived as having a holistic but fragmented responsibility for gout care, recommendations against keeping waiting lists complicated follow-up appointments and a need for motivation and support when introducing new practices was emphasised (context).

Conclusion

In this study, investigating the perspective of professionals, several factors were found to influence existing gout care. It will be crucial to target these factors in the development of a future implementation strategy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wood R, Fermer S, Ramachandran S, Baumgartner S, Morlock R. Patients with gout treated with conventional urate-lowering therapy: association with disease control, health-related quality of life, and work productivity. J Rheumatol. 2016;43(10):1897–903.CrossRef Wood R, Fermer S, Ramachandran S, Baumgartner S, Morlock R. Patients with gout treated with conventional urate-lowering therapy: association with disease control, health-related quality of life, and work productivity. J Rheumatol. 2016;43(10):1897–903.CrossRef
3.
go back to reference Richette P, Perez-Ruiz F, Doherty M, Jansen TL, Nuki G, Pascual E, et al. Improving cardiovascular and renal outcomes in gout: what should we target? Nat Rev Rheumatol. 2014;10(11):654–61.CrossRef Richette P, Perez-Ruiz F, Doherty M, Jansen TL, Nuki G, Pascual E, et al. Improving cardiovascular and renal outcomes in gout: what should we target? Nat Rev Rheumatol. 2014;10(11):654–61.CrossRef
4.
go back to reference Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F, et al. Gout. Nat rev Dis prim. 2019;5(1):69.CrossRef Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F, et al. Gout. Nat rev Dis prim. 2019;5(1):69.CrossRef
5.
go back to reference Drivelegka P, Sigurdardottir V, Svard A, Jacobsson LTH, Dehlin M. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy. Arthritis Res ther. 2018;20(1):108.CrossRef Drivelegka P, Sigurdardottir V, Svard A, Jacobsson LTH, Dehlin M. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy. Arthritis Res ther. 2018;20(1):108.CrossRef
6.
go back to reference Vargas-Santos AB, Neogi T, Rocha Castelar-Pinheiro G, Kapetanovic MC, Turkiewicz A. Cause-specific mortality in gout: novel findings of elevated risk of non-cardiovascular-related deaths. Arthritis Rheum. 2019;71(11):1935–42.CrossRef Vargas-Santos AB, Neogi T, Rocha Castelar-Pinheiro G, Kapetanovic MC, Turkiewicz A. Cause-specific mortality in gout: novel findings of elevated risk of non-cardiovascular-related deaths. Arthritis Rheum. 2019;71(11):1935–42.CrossRef
7.
go back to reference Chandratre P, Mallen C, Richardson J, Muller S, Hider S, Rome K, et al. Health-related quality of life in gout in primary care: baseline findings from a cohort study. Semin Arthritis Rheum. 2018;48(1):61–9.CrossRef Chandratre P, Mallen C, Richardson J, Muller S, Hider S, Rome K, et al. Health-related quality of life in gout in primary care: baseline findings from a cohort study. Semin Arthritis Rheum. 2018;48(1):61–9.CrossRef
8.
go back to reference Dehlin M, Ekstrom EH, Petzold M, Stromberg U, Telg G, Jacobsson LT. Factors associated with initiation and persistence of urate-lowering therapy. Arthritis Res Ther. 2017;19(1):6.CrossRef Dehlin M, Ekstrom EH, Petzold M, Stromberg U, Telg G, Jacobsson LT. Factors associated with initiation and persistence of urate-lowering therapy. Arthritis Res Ther. 2017;19(1):6.CrossRef
9.
go back to reference Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74(4):661–7.CrossRef Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74(4):661–7.CrossRef
10.
go back to reference Spencer K, Carr A, Doherty M. Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis. 2012;71(9):1490–5.CrossRef Spencer K, Carr A, Doherty M. Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis. 2012;71(9):1490–5.CrossRef
11.
go back to reference Rai SK, Choi HK, Choi SHJ, Townsend AF, Shojania K, De Vera MA. Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies. Rheumatology. 2018;57(7):1282–92.CrossRef Rai SK, Choi HK, Choi SHJ, Townsend AF, Shojania K, De Vera MA. Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies. Rheumatology. 2018;57(7):1282–92.CrossRef
14.
go back to reference Murphy B, Schumacher H. How does patient education affect gout? Clin Rheum Pract. 1984;2:77–80. Murphy B, Schumacher H. How does patient education affect gout? Clin Rheum Pract. 1984;2:77–80.
15.
go back to reference Yoo SJ, Kang SW, Shim SC, Kim J, Yoo IS, Park CK. The education of patients with gout improves the effects of treatment. Ann Rheum Dis. 2018;77(Suppl 2):1637. Yoo SJ, Kang SW, Shim SC, Kim J, Yoo IS, Park CK. The education of patients with gout improves the effects of treatment. Ann Rheum Dis. 2018;77(Suppl 2):1637.
16.
go back to reference Doherty M, Jenkins W, Richardson H, Sarmanova A, Abhishek A, Ashton D, et al. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. Lancet. 2018;392(10156):1403–12.CrossRef Doherty M, Jenkins W, Richardson H, Sarmanova A, Abhishek A, Ashton D, et al. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. Lancet. 2018;392(10156):1403–12.CrossRef
17.
go back to reference Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.CrossRef Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.CrossRef
18.
go back to reference Harvey G, Kitson A. PARIHS revisited: from heuristic to integrated framework for the successful implementation of knowledge into practice. Implement Sci. 2016;11:33.CrossRef Harvey G, Kitson A. PARIHS revisited: from heuristic to integrated framework for the successful implementation of knowledge into practice. Implement Sci. 2016;11:33.CrossRef
19.
go back to reference Polit DF, Beck CT. Nursing research: generating and assessing evidence for nursing practice. 11th ed. Philadelphia: Wolters Kluwer Health; 2021. Polit DF, Beck CT. Nursing research: generating and assessing evidence for nursing practice. 11th ed. Philadelphia: Wolters Kluwer Health; 2021.
20.
go back to reference Elo S, Kyngas H. The qualitative content analysis process. JAN. 2008;62(1):107–15.CrossRef Elo S, Kyngas H. The qualitative content analysis process. JAN. 2008;62(1):107–15.CrossRef
21.
go back to reference Kamberelis G, Dimitriadis G. Focus groups: from structured interviews to collective conversations. New York: Routledge; 2013.CrossRef Kamberelis G, Dimitriadis G. Focus groups: from structured interviews to collective conversations. New York: Routledge; 2013.CrossRef
23.
go back to reference Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N. The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol. 2011;17(1):1–6.CrossRef Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N. The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol. 2011;17(1):1–6.CrossRef
24.
go back to reference Vaccher S, Kannangara DR, Baysari MT, Reath J, Zwar N, Williams KM, et al. Barriers to care in gout: from prescriber to patient. J Rheumatol. 2016;43(1):144–9.CrossRef Vaccher S, Kannangara DR, Baysari MT, Reath J, Zwar N, Williams KM, et al. Barriers to care in gout: from prescriber to patient. J Rheumatol. 2016;43(1):144–9.CrossRef
25.
go back to reference Silberstein SD. Current management: migraine headache. CNS spectrums. 2017;22(S1):1–13.CrossRef Silberstein SD. Current management: migraine headache. CNS spectrums. 2017;22(S1):1–13.CrossRef
27.
go back to reference Abhishek A, Jenkins W, La-Crette J, Fernandes G, Doherty M. Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study. Rheumatology. 2017;56(4):529–33.PubMed Abhishek A, Jenkins W, La-Crette J, Fernandes G, Doherty M. Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study. Rheumatology. 2017;56(4):529–33.PubMed
28.
go back to reference Berglund E, Westerling R, Sundström J, Lytsy P. Treatment effect expressed as the novel delay of event measure is associated with high willingness to initiate preventive treatment: a randomized survey experiment comparing effect measures. Patient Educ Couns. 2016;99(12):2005–11.CrossRef Berglund E, Westerling R, Sundström J, Lytsy P. Treatment effect expressed as the novel delay of event measure is associated with high willingness to initiate preventive treatment: a randomized survey experiment comparing effect measures. Patient Educ Couns. 2016;99(12):2005–11.CrossRef
29.
go back to reference Gill I, Dalbeth N, 'Ofanoa M, Goodyear-Smith F. Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review. BJGP Open 2020;4(3): 20X101051.CrossRef Gill I, Dalbeth N, 'Ofanoa M, Goodyear-Smith F. Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review. BJGP Open 2020;4(3): 20X101051.CrossRef
31.
go back to reference God och nära vård - en primärvårdsreform. Socialdepartementet, editor. Stockholm: Statans offentliga utredningar; 2018. p. 544. God och nära vård - en primärvårdsreform. Socialdepartementet, editor. Stockholm: Statans offentliga utredningar; 2018. p. 544.
32.
go back to reference God och nära vård i samverkan. Socialdepartementet, editor. Stockholm: Statens offentliga utredningar; 2019. God och nära vård i samverkan. Socialdepartementet, editor. Stockholm: Statens offentliga utredningar; 2019.
33.
go back to reference Ekman I, Swedberg K, Taft C, Lindseth A, Norberg A, Brink E, et al. Person-centered care: ready for prime time. Eur J Cardiovasc Nurs. 2011;10(4):248–51.CrossRef Ekman I, Swedberg K, Taft C, Lindseth A, Norberg A, Brink E, et al. Person-centered care: ready for prime time. Eur J Cardiovasc Nurs. 2011;10(4):248–51.CrossRef
34.
go back to reference Abhishek A, Doherty M. Education and non-pharmacological approaches for gout. Rheumatology. 2018;57(suppl_1):i51–i8.CrossRef Abhishek A, Doherty M. Education and non-pharmacological approaches for gout. Rheumatology. 2018;57(suppl_1):i51–i8.CrossRef
35.
go back to reference Landsting SKo. Personcentrerad vård i Sverige. Stockholm: Sveriges kommuner och landsting; 2018. Landsting SKo. Personcentrerad vård i Sverige. Stockholm: Sveriges kommuner och landsting; 2018.
37.
go back to reference Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001;135:825–34.CrossRef Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001;135:825–34.CrossRef
38.
go back to reference Maravic M, Hincapie N, Pilet S, Flipo R-M, Lioté F. Persistent clinical inertia in gout in 2014: an observational French longitudinal patient database study. Joint Bone Spine. 2018;85(3):311–5.CrossRef Maravic M, Hincapie N, Pilet S, Flipo R-M, Lioté F. Persistent clinical inertia in gout in 2014: an observational French longitudinal patient database study. Joint Bone Spine. 2018;85(3):311–5.CrossRef
39.
go back to reference Cassidy CE, Harrison MB, Godfrey C, Nincic V, Khan PA, Oakley P, et al. Use and effects of implementation strategies for practice guidelines in nursing: a systematic review. Implement Sci. 2021;16(1):1–102.CrossRef Cassidy CE, Harrison MB, Godfrey C, Nincic V, Khan PA, Oakley P, et al. Use and effects of implementation strategies for practice guidelines in nursing: a systematic review. Implement Sci. 2021;16(1):1–102.CrossRef
42.
go back to reference Karimi-Shahanjarini A, Shakibazadeh E, Rashidian A, Hajimiri K, Glenton C, Noyes J, et al. Barriers and facilitators to the implementation of doctor-nurse substitution strategies in primary care: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2019;Issue 4. https://doi.org/10.1002/14651858.CD010412.pub2. Karimi-Shahanjarini A, Shakibazadeh E, Rashidian A, Hajimiri K, Glenton C, Noyes J, et al. Barriers and facilitators to the implementation of doctor-nurse substitution strategies in primary care: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2019;Issue 4. https://​doi.​org/​10.​1002/​14651858.​CD010412.​pub2.
Metadata
Title
Professionals’ perspectives on existing practice and conditions for nurse-led gout care based on treatment recommendations: a qualitative study in primary healthcare
Authors
Helene Sedelius
Malin Tistad
Ulrika Bergsten
Mats Dehlin
David Iggman
Lars Wallin
Anna Svärd
Publication date
01-12-2022
Publisher
BioMed Central
Keywords
Gout
Care
Published in
BMC Primary Care / Issue 1/2022
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/s12875-022-01677-z

Other articles of this Issue 1/2022

BMC Primary Care 1/2022 Go to the issue